Practice
Pharma & Healthcare Advisory
Industry insight where legal complexity drives value: licensing, IP, HCP/HCO compliance, sanctions, regulatory carve-outs and pharma-specific DD for sponsors and portfolio companies.
Industry insight where legal complexity drives value.
I support pharma and healthcare companies, PE sponsors and portfolio companies where legal, regulatory, compliance and IP topics directly affect valuation, deal certainty and operational execution.
Areas of Support
- Licensing, supply, distribution and strategic partnership agreements
- IP and patent strategy, ownership and chain-of-title reviews
- Compliance frameworks for pharma-specific business models
- HCP / HCO interaction models and promotional practices
- Sanctions, export control and high-risk market exposure
- Regulatory and operational separation issues in carve-outs
- Pharma-specific DD and exit readiness reviews
- Support for legal teams in complex or resource-constrained situations
Focus
Helping sponsors navigate pharma complexity with greater deal certainty.